Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells

Open access
Wade, Mark, Wong, Ee Tsin, Tang, Mengjia, Stommel, Jayne M., Wahl, Geoffrey M. · 2006 · Journal of Biological Chemistry

Abstract

Tumors that express wild-type P53 provide a target for therapies designed to reactivate P53 function. This is supported by the potent activation of P53 in tumor cells by Nutlin, a cis-imidazoline that inhibits the Hdm2-P53 interaction. The efficacy of Hdm2.P53 antagonists could be compromised if they do not antagonize Hdmx, an Hdm2 homolog that inhibits P53 transactivation. We evaluated the role of Hdmx expression in sensitivity to Nutlin in a range of cancer cell lines. Nutlin reduced Hdmx levels in normal cells and some cancer cell lines, whereas other cancer cells were refractory to such down-regulation. Strikingly, Nutlin did not disrupt Hdmx.P53 complexes, and in cell lines where no Hdmx degradation occurred, Nutlin failed to induce apoptosis. shRNA-mediated reduction of Hdmx sensitized cells to apoptosis, but caspase-3 was neither required nor sufficient for Hdmx degradation or apoptosis. Our data imply that Hdmx is an important determinant of the outcome of P53 activation. Thus, targeting Hdmx may be a therapeutic strategy that complements drugs such as Nutlin.

Overview

Integrity signals

Registry

Crossref · 10.1074/jbc.m605405200

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 3

  1. Schwartzberg, 2006, J. Support. Oncol., 42, 3
  2. Finch, 2002, Cancer Res., 62, 3221
  3. Tian, 2006, Biochem. Biophys. Res. Commun., 2, 2

Cited by

See all 166

Metadata

Authors
Wade, M., Wong, E. T., Tang, M., Stommel, J. M., & Wahl, G. M.
Affiliations
Salk Institute for Biological Studies (US)
Corresponding author
Wahl, Geoffrey M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2006-11
Volume
281
Issue
44
Pages
33036-33044
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2103069797
Cited by
163
References
57
Citations by year
2025: 2 · 2024: 4 · 2023: 11 · 2022: 1 · 2021: 2 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 9 · 2015: 7 · 2014: 8 · 2013: 13 · 2012: 13
FWCI
7.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (CA61449, R01CA061449)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords
HDMX, MDM2, p53 activation, nutlin, apoptosis, caspase-3, p53 transactivation, cancer cell lines, shRNA knockdown
MeSH terms
Humans, Imidazoles, Neoplasms, Nuclear Proteins, Piperazines, Protein Binding, Proto-Oncogene Proteins, Down-Regulation, Tumor Suppressor Protein p53, Apoptosis, Cell Cycle Proteins, RNA Interference, Cell Line, Tumor, Caspase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells. https://app.cochat.ai/papers/10.1074/jbc.m605405200
The paper
Wade, M., Wong, E. T., Tang, M., Stommel, J. M., & Wahl, G. M. (2006). Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m605405200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.